...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis
【24h】

Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis

机译:肺腺癌患者上皮-间质转化:与癌症干细胞标志物和预后的关系

获取原文
           

摘要

Adenocarcinoma is the most common histologic type of non-small cell lung carcinomas. The existence of lung cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) in human tissue is controversy. The aim of this study is to investigate the expression and clinical significance of CSCs and EMT markers and evaluate the correlation between the two in lung adenocarcinoma. A total of 97 cases comprise the tissue microarray from surgical resection for primary lung adenocarcinoma. Immunohistochemistry for ALDH1 and CD44 as CSC markers and E-cadherin, vimentin, fibronectin, SMA as EMT markers was performed. High ALDH1A1 expression was statistically associated with female gender (P=0.001), smoker (P=0.012), and high pT stages (P=0.046). High CD44 expression was statistically associated with female gender (P=0.008), non-smoker (P=0.000), and no pleural invasion (P=0.039). High expression of ALDH1 was associated with good overall survival (P=0.021). High expression of CD44 was correlated with both good overall survival (P=0.024) and disease-free survival (P=0.000). Vimentin expression was associated with pT stage (P=0.001) and pleural invasion (P=0.028). E-cadherin, fibronectin and SMA were not associated with clinicopathologic correlation and all EMT markers were not correlated with survival of lung adenocarcinoma. CSC markers expression was not related to EMT. Our results showed that the expression of CSCs was associated with a good prognosis in lung adenocarcinoma. The prognostic significance of EMT markers was skeptical in this study. There is a need for more research about CSC, EMT, and the relation between these two in human lung adenocarcinoma.
机译:腺癌是非小细胞肺癌最常见的组织学类型。人体组织中肺癌干细胞(CSC)和上皮-间质转化(EMT)的存在是有争议的。这项研究的目的是调查CSCs和EMT标记物的表达及其临床意义,并评估两者在肺腺癌中的相关性。总共97例病例包括外科手术切除的原发性肺腺癌组织芯片。免疫组化法检测ALDH1和CD44作为CSC标记,E-钙粘蛋白,波形蛋白,纤连蛋白,SMA作为EMT标记。 ALDH1A1高表达与女性(P = 0.001),吸烟者(P = 0.012)和高pT分期(P = 0.046)有统计学意义。 CD44的高表达与女性(P = 0.008),不吸烟(P = 0.000)和无胸膜浸润(P = 0.039)在统计学上相关。 ALDH1的高表达与良好的总体生存率相关(P = 0.021)。 CD44的高表达与良好的总生存期(P = 0.024)和无病生存期(P = 0.000)相关。波形蛋白的表达与pT分期(P = 0.001)和胸膜浸润(P = 0.028)相关。 E-钙黏着蛋白,纤连蛋白和SMA与临床病理相关性均不相关,所有EMT标记均与肺腺癌的存活率不相关。 CSC标记表达与EMT不相关。我们的结果表明,CSCs的表达与肺腺癌的良好预后相关。 EMT标志物的预后意义在这项研究中受到怀疑。在人类肺腺癌中,需要对CSC,EMT及其两者之间的关系进行更多的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号